ABBV-668
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABBV-668, covering 2024-10-08 to 2025-12-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis [Phase 2]